Evidence map›Paper›PMID 39364508›Full record

ArticleCureus2024

The Predictive Role of Indices Indirectly Indicating Hyperlipidemia and Inflammation in Ascending Aortic Aneurysm.

Hasan Sari, Yunus E Yavuz, Muhammed F Kaleli, Serhat Kesriklioglu, Yakup Alsancak

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hasan SariCardiology, Mut Statate Hospital, Mersin, TUR.
Yunus E YavuzCardiology, Siirt State Hospital, Siirt, TUR.
Muhammed F KaleliCardiology, Necmettin Erbakan University Faculty of Medicine, Konya, TUR.
Serhat KesrikliogluCardiology, Necmettin Erbakan University Faculty of Medicine, Konya, TUR.
Yakup AlsancakCardiology, Necmettin Erbakan University Faculty of Medicine, Konya, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Ascending aortic aneurysm (AAA) is an aortic disease that can progress with serious complications. The roles of hyperlipidemia and inflammation in its etiology are controversial. In this study, we aimed to investigate the predictive value of indices that can indirectly reflect hyperlipidemia and inflammation in patients with AAA. Methods This prospective study included 146 patients diagnosed with AAA and 88 controls. Demographic data, clinical history and laboratory results, including the atherogenic index of plasma (AIP), atherogenic coefficient (AC), pan-immune-inflammation value (PIV), and systemic immune-inflammation index (SII), were collected. Statistical analyses were performed to evaluate the relationships between these indices and the aortic diameter. Results Patients with AAA presented significantly higher PIV levels than controls did (p>0.05). However, no significant differences were observed in the AIP, AC, or SII between the patient and control groups. Furthermore, no significant correlation was found between the aortic diameter and the studied indices (p<0.05). PIV was the only significant parameter with a p-value of 0.026 (AUC: 0.587) according to the ROC analysis. Conclusion These findings suggest that while hyperlipidemia, as measured by the AIP and AC, may not play a direct role in AAA progression, inflammation indicated by PIV could be an important factor. Especially in resource-limited settings, these useful indicators can improve AAA management before the disease progresses to an advanced stage.

Indexed as

ascending aortic aneurysmatherogenic index of plasmahyperlipidemiainflammationpan-immune-inflammation valueprognostic indicators

Identifiers

PMID39364508
PMCPMC11448741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.